New Key Statistics Module, Z-Score and F-Score
SZSE:002864 Key Ratios
Market Cap ¥ M | 3,095.97 |
Enterprise Value ¥ M | 2,119.21 |
P/E(ttm) | 24.48 |
PE Ratio without NRI | 23.57 |
Forward PE Ratio | -- |
Price/Book | 1.96 |
Price/Sales | 3.04 |
Price/Free Cash Flow | 30.50 |
Price/Owner Earnings | 43.88 |
Payout Ratio % | 0.16 |
Revenue (TTM) ¥ M | 965.00 |
EPS (TTM) ¥ | 1.19 |
Beneish M-Score | -2.81 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 12.70 |
y-y EBITDA Growth Rate % | -5.70 |
EV-to-EBIT | 14.68 |
EV-to-EBITDA | 14.68 |
PEG | 1.86 |
Shares Outstanding M | 106.28 |
Net Margin (%) | 12.43 |
Operating Margin % | 13.26 |
Pre-tax Margin (%) | 14.47 |
Quick Ratio | 3.97 |
Current Ratio | 4.16 |
ROA % (ttm) | 5.85 |
ROE % (ttm) | 8.53 |
ROIC % (ttm) | 17.64 |
Dividend Yield % | 0.68 |
Altman Z-Score | 4.79 |
SZSE:002864 Number of Guru Trades
SZSE:002864 Volume of Guru Trades
Gurus Latest Trades with SZSE:002864
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002864 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shaanxi Panlong Pharmaceutical Group Ltd Insider Transactions
No Available Data